Company: Biogen
Posted by NeuroSciRep_41 · March 22, 2026
Tags: compensation
I went through a comp benchmarking exercise and I'm getting paid about 12-15% below what reps with my experience are pulling at AstraZeneca and Lilly right now.
Same therapeutic area, same call point complexity.
Biogen hasn't done a meaningful base adjustment in two years.
The bonus math also feels off — target is stated at 15% but actual payouts have been 9-11% for most of the team two years running.
I like the science and my manager is great but money is money.
Starting to take calls.
If you're negotiating an offer from Biogen, push hard on base — they have more room than the first number suggests.
17 upvotes · 0 comments